Mobile Site ›

Guidelines for Anticoagulation Therapy for Secondary Prevention After Deep Vein Thrombosis

Thrombophilia Testing

Slide 3

June 2011

However, there are a number of individuals who present with an acute venous thrombotic event for whom an acquired risk factor cannot be identified. For these patients, we then go on to perform thrombophilia testing as outlined in this slide. A full thrombophilia assessment would include measures of antithrombin, protein C and protein S deficiencies in addition to genetic testing for factor V Leiden and the prothrombin gene mutation. Both lupus-like anticoagulant testing and antiphospholipid antibody assessment is also warranted.

Thrombophilia Testing


Jump to section: